The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $72.07

Today's change-0.15 -0.21%
Updated December 8 4:02 PM EST. Delayed by at least 15 minutes.
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $72.07

Today's change-0.15 -0.21%
Updated December 8 4:02 PM EST. Delayed by at least 15 minutes.

Medtronic PLC down (U.S.)$0.15

Medtronic PLC closed lower Thursday, dropping (U.S.)$0.15 or 0.21% to (U.S.)$72.07. Over the last five days, shares have gained 0.26%, but sit 1.46% above the 52-week low. Shares have underperformed the S&P 500 by 16.55% during the last year.

Key company metrics

  • Open(U.S.) $72.11
  • Previous close(U.S.) $72.22
  • High(U.S.) $72.20
  • Low(U.S.) $71.42
  • Bid / Ask(U.S.) $71.40 / (U.S.) $72.77
  • YTD % change-6.31%
  • Volume9,466,183
  • Average volume (10-day)8,154,895
  • Average volume (1-month)7,453,651
  • Average volume (3-month)5,218,430
  • 52-week range(U.S.) $71.03 to (U.S.) $89.27
  • Beta0.95
  • Trailing P/E23.94×
  • P/E 1 year forward15.80×
  • Forward PEG2.07×
  • Indicated annual dividend(U.S.) $1.72
  • Dividend yield2.39%
  • Trailing EPS(U.S.) $3.01
Updated December 8 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.38%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 28, 201610/28/2016Jul 29, 201607/29/2016Apr 29, 201604/29/2016Jan 29, 201601/29/2016
Revenue7,3457,1667,5676,934
Total other revenue--------
Total revenue7,3457,1667,5676,934
Gross profit5,0194,9055,2044,793
Total cost of revenue2,3262,2612,3632,141
Total operating expense5,9605,9996,0625,579
Selling / general / administrative2,4162,4282,3602,317
Research & development554556575546
Depreciation / amortization500487483484
Interest expense (income), net operating--------
Unusual expense (income)7522830182
Other operating expenses, total8942-53-10
Operating income1,3851,1671,5051,355
Interest income (expense), net non-operating-264-272-481-275
Gain (loss) on sale of assets--------
Other--------
Income before tax1,2129881,1341,179
Income after tax1,1119291,1031,095
Income tax, total101593184
Net income1,1119291,1031,095
Total adjustments to net income--------
Net income before extra. items1,1119291,1031,095
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,1119291,1031,095
Inc. avail. to common incl. extra. items1,1119291,1031,095
Diluted net income1,1119291,1031,095
Dilution adjustment--------
Diluted weighted average shares1,3931,4071,4161,422
Diluted EPS excluding extraordinary itemsvalue per share0.800.660.780.77
Dividends per sharevalue per share0.430.430.380.38
Diluted normalized EPSvalue per share0.850.810.990.82